The model outputs a Neutral rating for Ayr Wellness, scoring 46/100 at conviction 2 of 5. The composite is a fixed blend of four pillars — fundamentals at 35 percent, regulatory at 25, market at 25, and editorial at 15 — and each contribution is inspectable. The strongest contribution comes from the regulatory pillar at 58, and pulls the composite into the middle of the band. Editorial lags at 30, softening what would otherwise be a stronger reading.
Pillar-level, the record reads as reported revenue growth of -9.1 percent year over year, an operating margin of -18.4 percent. Each of those data points tethers the Neutral conclusion to observable evidence. Every input flowing into the pillar table comes from primary regulatory filings, licensed fundamentals data, and institutional pricing feeds, filtered through CIN newsroom density. The 336-ticker CIN universe is scored deterministically, so Ayr Wellness can be compared against the global cannabis coverage universe on identical inputs, refreshed on the ingest cycle.
The rating turns on regulatory pace. Filings landing at above the trailing-90-day cadence, combined with an unblemished enforcement record, would carry Ayr Wellness above the Neutral anchor; a lull would soften the read.
Bullish and Bearish Analyst Opinions for Ayr Wellness (AYRWF)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Ayr Wellness (AYRWF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
Bullish and bearish analyst opinions for Ayr Wellness (AYRWF)
Bullish view. Ayr Wellness operates verticals in Florida, Massachusetts, Pennsylvania, Ohio, and New Jersey and has been a wholesale share gainer in Massachusetts and Ohio; bulls model Florida adult-use as a step-change catalyst if the referendum passes, and Ohio as a leverageable adult-use market that scaled quickly.
Bearish view. Bearish views cite Ayr's balance-sheet leverage, near-term note maturities that require refinancing at higher rates, and the general MSO peer-group multiple compression that has affected leveraged names disproportionately.
5-year weekly price history, intraday quotes, and 52-week range for AYRWF are maintained by Cannabis Investor News and refreshed throughout the trading day.